These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 12402403)
1. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication. Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403 [TBL] [Abstract][Full Text] [Related]
2. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ; Zhang C Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208 [TBL] [Abstract][Full Text] [Related]
3. Activation of tat-defective human immunodeficiency virus by ultraviolet light. Sadaie MR; Tschachler E; Valerie K; Rosenberg M; Felber BK; Pavlakis GN; Klotman ME; Wong-Staal F New Biol; 1990 May; 2(5):479-86. PubMed ID: 1981148 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV production in cells containing an integrated, HIV-regulated diphtheria toxin A chain gene. Harrison GS; Long CJ; Maxwell F; Glode LM; Maxwell IH AIDS Res Hum Retroviruses; 1992 Jan; 8(1):39-45. PubMed ID: 1736939 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991 [TBL] [Abstract][Full Text] [Related]
6. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1. Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Popik W; Pitha PM Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218 [TBL] [Abstract][Full Text] [Related]
8. The tat gene and protein of the human immunodeficiency virus type 1. Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763 [No Abstract] [Full Text] [Related]
9. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. Bohne J; Kräusslich HG FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733 [TBL] [Abstract][Full Text] [Related]
10. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Wu Y; Marsh JW Science; 2001 Aug; 293(5534):1503-6. PubMed ID: 11520990 [TBL] [Abstract][Full Text] [Related]
11. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs. Kashanchi F; Sadaie MR; Brady JN Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142 [TBL] [Abstract][Full Text] [Related]
13. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity. Nahreini P; Mathews MB Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945 [TBL] [Abstract][Full Text] [Related]
14. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef. Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF; J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263 [TBL] [Abstract][Full Text] [Related]
15. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. Poon B; Chang MA; Chen IS J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391 [TBL] [Abstract][Full Text] [Related]
16. [Influence of regulatory genes of type 1 human immunodeficiency virus on proliferation and differentiation of murine embryonic stem cells]. Manuilova ES; Arsen'eva EL; Khaĭdarova NV; Shugurova IM; Gornostaeva SN; Inozemtseva LS; Katrukha AI; Grivennikov IA; Tarantul VZ Ontogenez; 2003; 34(3):204-10. PubMed ID: 12816051 [TBL] [Abstract][Full Text] [Related]
17. Tat is required for efficient HIV-1 reverse transcription. Harrich D; Ulich C; García-Martínez LF; Gaynor RB EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139 [TBL] [Abstract][Full Text] [Related]
18. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1. Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Han W; Wind-Rotolo M; Kirkman RL; Morrow CD Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848 [TBL] [Abstract][Full Text] [Related]
20. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]